Author

Kendall L. Anderson

ORCID 0000-0001-6519-0675Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Gayatri AruniD· 2 shared Martin AkermaniD· 2 shared Adam Geier· 1 shared Alexey S. RevenkoiD· 1 shared Alyssa D FronkiD· 1 shared David L. SpectoriD· 1 shared Disha AggarwaliD· 1 shared James A. RouseiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gayatri ArunORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 27, 2026

Patient-derived organoid xenografts reveal the multifaceted role of the lncRNA MALAT1 in breast cancer progression

Disha Aggarwal, Suzanne Russo, Kendall L. Anderson…·David L. Spector

This study evaluates MALAT1-targeting ASOs in breast cancer using patient-derived organoid models, showing MALAT1's role in alternative splicing, metastasis, and tumor-stroma interactions.

DOI 10.64898/2026.04.02.716096

humanorganoid / primary culture

𝕏 PostBluesky

BioinformaticsbioRxivPreprintOct 14, 2022

Development and validation of an AI/ML platform for the discovery of splice-switching oligonucleotide targets

Alyssa D Fronk, Miguel Ángel Manzanares, Paulina Zheng…·Martin Akerman

This paper develops SpliceLearn, an AI/ML tool for identifying splice-switching oligonucleotide targets, and validates its effectiveness in predicting therapeutic targets in triple negative breast cancer.

DOI 10.1101/2022.10.14.512313

humanbulk RNA-seq

𝕏 PostBluesky